We are live on ! Find out more
RXIIW

RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW

Delisted

RXIIW was delisted on the 16th of November, 2018.

Back to rankings

4 hedge funds and large institutions have $850K invested in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

27% less capital invested

Capital invested by funds: $1.16M → $850K (-$310K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$104K
2
SM
Sabby Management
Florida
-$3.53K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$400K -$3.53K -17,995 -0.8%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$400K – – –
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$45K -$104K -532,132 -68%
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$5K – – –

RXIIW Hedge Fund Activity: Q2 2017 in Review

4 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) for Q2 2017, worth a combined $850K — down 27% from $1.16M a quarter earlier.

Fund positioning in RXIIW was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Hudson Bay Capital Management, cutting an estimated $104K.

  • 4 institutional investors held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $850K of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 stock for Q2 2017, down 27% quarter-over-quarter.
  • 0 funds opened new RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 positions in Q2 2017 and 0 closed out.
  • The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 seller in Q2 2017 was Hudson Bay Capital Management, an estimated $104K sold.

Based on aggregated 13F filings for Q2 2017.